AACR Congratulates Edwin A. Mirand, Ph.D., D.Sc., on Receiving a Lifetime Achievement Award
PHILADELPHIA — The American Association for Cancer Research congratulates Edwin A. Mirand, Ph.D., D.Sc., vice president emeritus for educational affairs and senior advisor to Roswell Park Cancer Institute President and CEO Donald L. Trump, M.D., on receiving a Lifetime Achievement Award from the institute.
“Dr. Mirand has had an incredible impact on cancer research, providing leadership and sage advice for many years on both science and public policy,” said Margaret Foti, Ph.D., M.D. (h.c.), chief executive officer of the AACR. “It is most fitting that he should receive a lifetime achievement award from his institution for these amazing contributions to the great cancer centers in the U.S. and to the cancer field as a whole. AACR is proud to have him as a friend, colleague and esteemed active member since 1954.”
In the early 1970s, Mirand and colleagues developed the first public cancer education program, called the CAN-DIAL information telephone line. He also played an instrumental role in getting the National Cancer Act of 1971 signed into law, which made cancer research a high national priority. As a researcher, Mirand has made noteworthy contributions to the fields of viral carcinogenesis, erythropoiesis and gnotobiology, and developed the Hauschka-Mirand ICR germ-free mouse strain.
Mirand was appointed director of Roswell Park Cancer Institute’s Springville Laboratories in 1951. He went on to lead its departments of biology, viral oncology and biological resources and its laboratories in West Seneca, N.Y., while establishing and expanding the institute’s education programs. He developed what would become the world’s longest-running summer program in cancer research for gifted and talented high school and college students.
“Dr. Mirand has been part of the fabric of Roswell Park Cancer Institute for nearly 60 years,” said Trump. “He helped to build and to lead the Institute at key points in its history, playing a critical role in planning and decision-making that ultimately benefited people far outside our immediate reach. Dr. Mirand has made incalculable contributions worldwide, and his lifelong commitment to Roswell Park, its patients and its mission is exemplary.”
Mirand has served as president of the Association for Gnotobiotics and the International Society of Gnotobiology, secretary-treasurer of the American Association of Cancer Institutes (AACI), and secretary-general of the International Union Against Cancer (UICC) 13th International Cancer Congress, held in Seattle, Wash., in 1982.
A Buffalo native and resident, Mirand is a graduate of the University at Buffalo, where he earned an undergraduate degree in biology and chemistry and a master’s degree in biology. He graduated from Syracuse University in 1951 with a doctor of philosophy in medical science.
Among the many awards and honors Mirand has received are the Billings Medal in Science from the American Medical Association, in 1963; the Merit Award from the UICC, in 1982; and the Special Recognition Award from the AACI, in 2004. He holds honorary doctorates from Niagara University and D’Youville College.
# # #
The mission of the American Association for Cancer Research is to prevent and cure cancer. Founded in 1907, the AACR is the world’s oldest and largest professional organization dedicated to advancing cancer research. The membership includes 31,000 basic, translational and clinical researchers; health care professionals; and cancer survivors and advocates in the United States and more than 90 other countries. The AACR marshals the full spectrum of expertise from the cancer community to accelerate progress in the prevention, diagnosis and treatment of cancer through high-quality scientific and educational programs. It funds innovative, meritorious research grants, research fellowship and career development awards. The AACR Annual Meeting attracts more than 17,000 participants who share the latest discoveries and developments in the field. Special conferences throughout the year present novel data across a wide variety of topics in cancer research, treatment and patient care. The AACR publishes six major peer-reviewed journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; Cancer Epidemiology, Biomarkers & Prevention; and Cancer Prevention Research. The AACR also publishes CR, a magazine for cancer survivors and their families, patient advocates, physicians and scientists. CR provides a forum for sharing essential, evidence-based information and perspectives on progress in cancer research, survivorship and advocacy.